Joseph H. Wender, Director at ISIS PHARMACEUTICALS INC (ISIS), sold 19,731 shares at $39.13 ($781K) on 2013-12-19, disclosed to the SEC on 2013-12-20.
Open-market sale of $781k ISIS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.13 | 9,731 | $381K | 48.8% |
| 2 | $40.01 | 10,000 | $400K | 51.2% |
| Total | $39.58 avg | 19,731 | $781K | 100% |
| Filing → |
| IONS | SELL | 2025-10-02 | $1.1M | — | Filing → |
| IONS | SELL | 2025-09-04 | $1.6M | — | Filing → |
| IONS | SELL | 2019-03-20 | $796K | — | Filing → |